Pinote, Myrna M.

HRN: 23-46-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2023
CEFTRIAXONE 1G (VIAL)
08/02/2023
08/08/2023
IV
2g
OD
CAP MR
Waiting Final Action 
08/02/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/02/2023
08/06/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
08/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2023
08/16/2023
IVT
1.5g
Q8H
CAP-MR, Bronchial Asthma In AE
Waiting Final Action 
08/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/11/2023
08/16/2023
IVTT
1.5g
Q6h
CAP-MR; BA In AE
Waiting Final Action 
03/29/2026
CEFTRIAXONE 1G (VIAL)
03/29/2026
04/04/2026
IV
2g
OD
Cap Mr
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: